Table 2.
Sociodemographic and clinical characteristics of 67 alcoholic liver disease patients
Mean | Range or standard deviation | No./No. responded | Percentage | |||
Age1 (yr) | 50.2 | 28-69 | Adherence of medical treatment | Present | 45/67 | 67 |
Gender2 (male/female) | 48/19 | Absent | 20/67 | 30 | ||
Hepatic encephalopathy2 (point) | 1.2 | 0.4 | Unknown | 2/67 | 3 | |
Ascites2 (point) | 2.0 | 0.8 | Being at work or ready to work | Present | 47/67 | 70 |
Bilirubin2 (mg/dL) | 6.1 | 6.0 | Absent | 18/67 | 27 | |
Albumin2 (g/dL) | 2.8 | 0.5 | Unknown | 2/67 | 3 | |
International normalized ratio of prothrombin time2 | 1.83 | 0.7 | Understanding and agreement of transplant and a support by the family | Present | 61/67 | 91 |
Creatinine2 (mg/dL) | 0.9 | 0.6 | Absent | 6/67 | 9 | |
Model for end-stage liver disease score2 (point) | 1.9 | 7.0 | Presence of psychiatric comorbidity except alcohol-related mental disease | Present | 2/67 | 3 |
Child-Pugh score2 (point) | 10.1 | 2.0 | Absent | 65/67 | 97 | |
Duration of heavy drinking2 (yr) | 21.7 | 10.4 | Declaration of abstinence | Present | 55/67 | 82 |
Usual number of daily drinks2 (L) | 2.1 | 0.8 | Absent | 12/67 | 18 | |
The HRAR scale2 (point) | 2.3 | 1.0 | Psychiatric hospitalizations | Present | 1/67 | 1 |
Prothrombin time2 (%) | 34.3 | 16.4 | Absent | 66/67 | 99 | |
Abstinence period2 (mo) | 12.1 | 15.8 |
Result was shown as mean and range;
Results were shown as mean and SD. HRAR: High-Risk Alcoholism Relapse.